PROSCIA
Proscia develops a digital pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes. Its platform utilizes computing technologies that unlock hidden data not visible to the human eye and turns that data into valuable insights to help physicians accelerate the development of life-saving advances.
PROSCIA
Industry:
Artificial Intelligence (AI) Biotechnology Life Science Medical
Founded:
2014-07-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.proscia.com
Total Employee:
101+
Status:
Active
Contact:
1 215 608-5411
Email Addresses:
[email protected]
Total Funding:
80.52 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag
Similar Organizations
BioMap
BioMap is an AI driven research and development platform focusing on precision medicine.
Capra Biosciences
Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Element Biosciences
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
Myricx Pharma
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.
NOWDiagnostics
NOWDiagnostics develops and manufactures diagnostic tests that utilize a single drop of blood and deliver results within minutes.
Pacific Biosciences
Pacific Biosciences designs, develops, and manufactures sequencing systems to resolve genetically complex problems.
Zephyr AI
Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.
Current Advisors List
Current Employees Featured
Founder
Investors List
Triangle Peak Partners
Triangle Peak Partners investment in Series C - Proscia
Emerald Development Managers
Emerald Development Managers investment in Series C - Proscia
Alpha Intelligence Capital
Alpha Intelligence Capital investment in Series C - Proscia
Scale Venture Partners
Scale Venture Partners investment in Series C - Proscia
ROBO Global
ROBO Global investment in Series C - Proscia
Robin Hood Ventures
Robin Hood Ventures investment in Series C - Proscia
Razor's Edge Ventures
Razor's Edge Ventures investment in Series C - Proscia
Fusion Fund
Fusion Fund investment in Series C - Proscia
Hitachi Ventures
Hitachi Ventures investment in Series C - Proscia
Flybridge
Flybridge investment in Series C - Proscia
Official Site Inspections
http://www.proscia.com Semrush global rank: 1.42 M Semrush visits lastest month: 17.99 K
- Host name: 204.119.68.34.bc.googleusercontent.com
- IP address: 34.68.119.204
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Proscia"
Company | Proscia
Proscia is a software company accelerating pathology’s transformation toward a data-driven discipline. Our Concentriq® digital pathology platform and powerful AI applications are …See details»
Proscia - Crunchbase Company Profile & Funding
Proscia develops a digital pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes. Its platform utilizes computing technologies that unlock hidden data not visible to …See details»
Proscia Company Profile 2024: Valuation, Funding
Proscia General Information Description. Developer of a digital pathology platform designed to enhance cancer diagnosis. The company's platform uses computing technologies that unlock hidden data not visible to the human eye and turn …See details»
Proscia – Pathology News
About Proscia. We’re on a mission to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology. Proscia is bringing a fresh approach to an …See details»
Proscia - Funding, Financials, Valuation & Investors - Crunchbase
Proscia is funded by 14 investors. Triangle Peak Partners and Emerald Development Managers are the most recent investors. Proscia has a post-money valuation in the range of $100M to …See details»
Proscia Company Profile - Office Locations, Competitors ... - Craft
Proscia is a company that develops cancer diagnostics software. It offers Concentriq enterprise pathology platform for image and workflow management, an AI-enabled application Automated …See details»
Proscia
Proscia is a software company that is accelerating pathology’s transformation toward a data-driven discipline. Our Concentriq ® digital pathology platform and powerful AI applications are unlocking new insights that accelerate discovery, …See details»
CellNetix Selects Proscia To Deliver New Standard Of …
Dec 6, 2023 Proscia’s user base is made up of over 10,000 pathologists and scientists, including those from 14 of the top 20 pharmaceutical companies and leading anatomic pathology laboratories. About CellNetix Pathology & …See details»
Proscia - VentureRadar
Proscia develops solutions that help customers harness their digital pathology data, recognizing patterns in pixels, turning conjectures into conclusions, and creating new avenues of …See details»
Proscia Wins Fast Company’s Next Big Things in Tech Award
Nov 22, 2024 Proscia’s Concentriq is an enterprise pathology platform that shifts the standard from microscope to data-rich images and enables the use of AI to unlock new insights from …See details»
Proscia Announces Major Expansion In Preclinical R&D To Drive …
PHILADELPHIA – March 20, 2023 – Proscia ®, a leading provider of digital and computational pathology solutions, has strengthened its position in the $12 billion [1] preclinical research and …See details»
Proscia Strengthens Leadership Position In Global Diagnostic …
Jun 26, 2024 New KLAS Research report and research study conducted with Quest Diagnostics highlight company’s customer and product momentum. PHILADELPHIA – JUNE 26, 2024 – …See details»
Proscia Raises $37M Series C to Fulfill the Promise of Precision ...
Jun 14, 2022 "Proscia is uniquely positioned to enable a new frontier of patient care," said Jacob Doft, CEO of Highline Capital Management."Digital pathology is a critical catalyst in the …See details»
Proscia Upgrades Flagship Software to Enable Rapid …
Jun 8, 2021 Proscia’s Concentriq is the platform of choice for leading organizations, including LabPON, the Joint Pathology Center, and University Medical Center Utrecht.See details»
Proscia - Quantifying the Value of AI-Powered Digital Workflows …
In a recent collaboration, Quest, Ibex, and Proscia ran a feasibility study* designed to understand how AI-powered diagnostics, delivered through an enterprise digital pathology platform, would …See details»
AI - Proscia
Proscia makes it easy for scientists and pathologists to use AI to take on their biggest challenges, accelerate the development of novel therapies and deliver precision diagnostics. As pathology …See details»
Organize, Analyze, & Share Tissue Data Across Your Institution …
Find out with Proscia, the first end-to-end digital pathology solution that makes tissue data searchable and accessible for any number of users in an academic medical environment. …See details»
Instem And Proscia Partner To Accelerate Preclinical Development …
Jun 17, 2024 Concentriq integration will help Provantis users drive GLP and non-regulated toxicologic pathology studies. PHILADELPHIA – June 17, 2024 – Instem, a leading provider of …See details»
Real-World Data - Proscia
Sep 4, 2024 Proscia is enabling life sciences to accelerate critical milestones from discovery to development with the power of pathology images matched to clinical and genomic data at …See details»